Pyrimidine, 5-bromo-2-methoxy- → 3-Cyclobutyl-7-{[2-(methyloxy)-5-pyrimidinyl]oxy)-2,3,4,5-tetrahydro-1H-3-benzazepine

HRID 641500Notes

Reaction equation

HRID 641500 reaction equation
[CH:1]1([N:5]2[CH2:11][CH2:10][C:9]3[CH:12]=[C:13]([OH:16])[CH:14]=[CH:15][C:8]=3[CH2:7][CH2:6]2)[CH2:4][CH2:3][CH2:2]1.Br[C:18]1[CH:19]=[N:20][C:21]([O:24][CH3:25])=[N:22][CH:23]=1>>[CH:1]1([N:5]2[CH2:6][CH2:7][C:8]3[CH:15]=[CH:14][C:13]([O:16][C:18]4[CH:19]=[N:20][C:21]([O:24][CH3:25])=[N:22][CH:23]=4)=[CH:12][C:9]=3[CH2:10][CH2:11]2)[CH2:4][CH2:3][CH2:2]1

Participants

3

Procedure

Example 144 (E144) was prepared from 3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol (E3) and 5-bromo-2-(methyloxy)pyrimidine (PCT Int. Appl. PCT (2002), WO 02/62423) using the method described for Example 140 (E140); MS (ES+) m/e 326 [M+H]+.

Sources & evidence

ORD record
ord-0bd286fbdd1948769681fd6d9a7d884e
Source dataset
uspto-grants-2010_04
Patent number
US07696193B2

Reaction notes

Loading…